Sonoyama T, Iwata S, Shinkai M, Iwata-Yoshikawa N, et al. Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults. Vaccine 2022 Dec 16:S0264-410X(22)01540-7. doi: 10.1016/j.vaccine.2022.
PMID: 36572603